Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry
Pietro Iaffaldano(University of Bari Aldo Moro), Augusto Rini(Ospedale A. Perrino), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Diana Ferraro(Azienda Ospedaliero-Universitaria di Modena), Girolama Alessandra Marfia(Erasmus University Rotterdam), Alessandra Protti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Roberto Bergamaschi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Franco Granella(University of Parma), Paola Valentino(Magna Graecia University), Franco Di Palma(Azienda Socio Sanitaria Territoriale Lariana), Antonella Conte(Sapienza University of Rome), Maria Sessa(Ospedale Papa Giovanni XXIII), Tommaso Guerra(University of Bari Aldo Moro), Carlo Avolio(University of Foggia), Umberto Aguglia(Martin University), Davide Maimone(Ospedale Garibaldi), Claudio Gasperini(Nini Hospital), Valentina Torri Clerici, Alessandra Lugaresi(Istituto delle Scienze Neurologiche di Bologna), Ilaria Pesci, Alessia Di Sapio(Neuroscience Institute), Francesco Logullo(Marche Polytechnic University), Sara Montepietra, Giovanna De Luca(University of Udine), Rocco Totaro(San Salvatore Hospital), E. Di Monte(Ospedale Madonna Delle Grazie), Marco Rovaris(San Raffaele University of Rome), Elisabetta Ferraro(IRCCS Ospedale San Raffaele), Matilde Inglese(New York University), Paola Cavalla, Paola Gazzola(University of Genoa), Daniele Spitaleri(Azienda Ospedaliera S.Giuseppe Moscati), Francesco Patti(University of Catania), Giuseppe Salemi, Guido Cavaletti(Bellvitge University Hospital), Silvia Romano, Carlo Pozzilli(Sapienza University of Rome), Giacomo Lus(University of Campania "Luigi Vanvitelli"), Eleonora Cocco(University of Cagliari), Vincenzo Brescia Morra(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Milena De Riz, Giorgia Teresa Maniscalco(Ospedale Antonio Cardarelli), Paolo Bellantonio(Vita-Salute San Raffaele University), Gioacchino Tedeschi(University of Campania "Luigi Vanvitelli"), Marika Vianello(Ca' Foncello Hospital), Francesca De Robertis(University of Bari Aldo Moro), Giuseppe Lucisano(Center for Outcomes Research and Clinical Epidemiology), Daniela Cargnelutti(Multiple Sclerosis Foundation), Maura Danni(Multiple Sclerosis Foundation), Maurizia Gatto(Ospedale Generale Regionale Francesco Miulli)
Cited by 6
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Multiple Sclerosis Severity Score
|Neurology|2005|959